Compare SBCF & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SBCF | HTFL |
|---|---|---|
| Founded | 1926 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2009 | N/A |
| Metric | SBCF | HTFL |
|---|---|---|
| Price | $30.53 | $29.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $38.00 | ★ $38.20 |
| AVG Volume (30 Days) | 810.8K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $45.04 | $27.66 |
| Revenue Next Year | $6.30 | $23.55 |
| P/E Ratio | $105.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.46 | $20.13 |
| 52 Week High | $35.55 | $41.22 |
| Indicator | SBCF | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 52.34 |
| Support Level | $29.26 | $28.60 |
| Resistance Level | $32.23 | $32.71 |
| Average True Range (ATR) | 0.72 | 1.92 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 43.58 | 62.61 |
Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.